← Browse by Condition
Medical Condition
metastatic urothelial carcinoma
Total Trials
5
Recruiting Now
5
Trial Phases
Phase 2, Phase 1, Phase 2, Phase 3
ClinicalMetric tracks all active clinical trials for metastatic urothelial carcinoma sourced from ClinicalTrials.gov. Research in this area spans early-phase safety investigations through large Phase 3 confirmatory trials, conducted by NIH-funded academic centers, independent investigators, and pharmaceutical sponsors worldwide. Each listing is updated daily as new studies open enrollment and existing ones reach capacity or complete follow-up.
Trial listings include the NCT identifier, current recruitment status, phase classification, primary and secondary endpoints, estimated enrollment size, participating countries, and direct links to the full protocol on ClinicalTrials.gov. Eligibility criteria — including age range, disease stage, and prior treatment requirements — are documented for every study to help patients and clinicians assess suitability before contacting a trial site.
Frequently Asked Questions — metastatic urothelial carcinoma Clinical Trials
How many clinical trials are currently recruiting for metastatic urothelial carcinoma?
ClinicalMetric currently tracks 5 actively recruiting clinical trials for metastatic urothelial carcinoma, sourced in real time from ClinicalTrials.gov. The total number of registered studies—including those not yet enrolling or in active follow-up—is 5. Trial availability changes daily as new studies open enrollment and existing ones reach capacity.
What trial phases are available for metastatic urothelial carcinoma?
metastatic urothelial carcinoma research spans Phase 1 (1 trial), Phase 2 (3 trials), Phase 3 (2 trials). Phase 1 studies evaluate safety and dosing in small groups, Phase 2 studies assess preliminary efficacy in 100–300 participants, and Phase 3 trials compare the new treatment against the standard of care in 300–3,000+ patients. Phase 4 post-approval studies monitor long-term outcomes in real-world populations.
How do I find out if I qualify for a metastatic urothelial carcinoma clinical trial?
Eligibility criteria for metastatic urothelial carcinoma trials vary by study and typically specify age range, disease stage or severity, prior treatment history, and specific diagnostic or laboratory parameters. Each listing on ClinicalMetric links to the full protocol on ClinicalTrials.gov, where inclusion and exclusion criteria are documented. Contact the sponsoring site's research coordinator directly to confirm your eligibility—your treating physician or specialist can also help identify the most appropriate trial based on your medical history and current treatment status.
Trial Phases
Phase 1 1
Phase 2 3
Phase 3 2
Top Sponsors
1 trial
1 trial
1 trial
1 trial
1 trial
Recruiting Clinical Trials
NCT05733000 Phase 2
Recruiting
Enrollment
94 pts
Location
United States
Sponsor
Northwestern University
NCT05107674 Phase 1
Recruiting
Enrollment
345 pts
Location
United States, Unite...
Sponsor
Nurix Therapeutics, Inc.
NCT06493552 Phase 2, Phase 3
Recruiting
Enrollment
700 pts
Location
United States
Sponsor
Vasgene Therapeutics, Inc
NCT07221942 Phase 2
Recruiting
Enrollment
97 pts
Location
United States
Sponsor
Fox Chase Cancer Center
NCT06524544 Phase 3
Recruiting
Enrollment
320 pts
Location
United States
Sponsor
National Cancer Institute (NCI...
Related Conditions
advanced urothelial carcinoma (2) unresectable urothelial carcinoma (2) advanced biliary tract carcinoma (1) advanced colorectal carcinoma (1) advanced gastroesophageal junction adenocarcinoma (1) advanced lung adenocarcinoma (1) advanced malignant solid neoplasm (1) advanced ovarian carcinoma (1) advanced pancreatic carcinoma (1) clinical stage iii gastroesophageal junction adenocarcinoma ajcc v8 (1) clinical stage iv gastroesophageal junction adenocarcinoma ajcc v8 (1) metastatic biliary tract carcinoma (1)
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: November 2026 · Data Methodology